Evidence map›Paper›PMID 18832708›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Liljana Stevceva, Victor Yoon, Angela Carville, Beatriz Pacheco, Michael Santosuosso, Birgit Korioth-Schmitz, Keith Mansfield, Mark C Poznansky

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. T-Cell Signaling in HIV-1 Infection.The open virology journal · 2013
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Liljana StevcevaPartners AIDS Research Center and Infectious Diseases Medicine, Massachusetts General Hospital (East), Charlestown, MA 02129, USA. lstevceva@hotmail.com
Victor Yoon
Angela Carville
Beatriz Pacheco
Michael Santosuosso
Birgit Korioth-Schmitz
Keith Mansfield
Mark C Poznansky
Massachusetts General Hospital · USNew England Biolabs (United States) · USBeth Israel Deaconess Medical Center · USHarvard University · US

Funding

Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
HIV-1 gp120 induced CTL chemorepulsion:dysregulation of migration & localizationR01AI049757 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI POZNANSKY, MARK COLEMAN · 2001 to 2010
$4.0M
NIAID NIH HHS R01 AI049757NIAID NIH HHS R01 AI49757NIAID NIH HHS T32 AI007387PHS HHS T32A1007387
6 · The paper itself

Abstract

Gp120 is a critical component of the envelope of HIV-1. Its role in viral entry is well described. In view of its position on the viral envelope, gp120 is a part of the retrovirus that immune cells encounter first and has the potential to influence antiretroviral immune responses. We propose that high levels of gp120 are present in tissues and may contribute to the failure of the immune system to fully control and ultimately clear the virus. Herein, we show for the first time that lymphoid tissues from acutely HIV-1/SIV (SHIV)-KB9-infected macaques contain deposits of gp120 at concentrations that are high enough to induce suppressive effects on T cells, thus negatively regulating the antiviral CTL response and contributing to virus survival and persistence. We also demonstrate that SHIV-KB9 gp120 influences functional T cell responses during SHIV infection in a manner that suppresses degranulation and cytokine secretion by CTLs. Finally, we show that regulatory T cells accumulate in lymphoid tissues during acute infection and that they respond to gp120 by producing TGFbeta, a known suppressant of cytotoxic T cell activity. These findings have significant implications for our understanding of the contribution of non-entry-related functions of HIV-1 gp120 to the pathogenesis of HIV/AIDS.

Indexed as

Acquired Immunodeficiency SyndromeAnimalsCD8-Positive T-LymphocytesCHO CellsCricetinaeCricetulusHIV-1HIV Envelope Protein gp120HumansImmunity, CellularLymphoid TissueMacaca mulattaMembrane GlycoproteinsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocytes, Regulatorygp120 protein, Human immunodeficiency virus 1gp120 protein, Simian immunodeficiency virusHIV Envelope Protein gp120Membrane GlycoproteinsTransforming Growth Factor betaViral Envelope Proteins

Identifiers

PMID18832708
PMCPMC4236110
OpenAlexW1933713637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.